FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

Ahead of teasing the first exhibitors for this year’s FOS Future Lab presented by Randox, we’ve taken a look at MIT ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

As talk of Mars colonisation and permanent lunar bases accelerates, scientists are issuing a stark warning: human ...

Fertility care has evolved significantly over the last few decades and is now offering structured solutions to indivi ...

In cow-calf systems, many of the factors that determine productivity, fertility and longevity are set long before a ...

Svenja Kling is a fifth-year PhD student studying marine biology at UC San Diego’s Scripps Institution of Oceanography. Kling ...

Innovations allowing women to have a child past the usual childbearing age could only further incentivize people to wait to ...

The architecture of the body is not encoded as a formal blueprint; rather, it's the tightly orchestrated activation and ...

This rare condition occurs when an abdominal pregnancy ends and the body calcifies foetal remains as a protective response.

Why does the face scar less than the rest of the body? New research uncovers the cellular pathway behind this difference.

The TV presenter discusses her breakout role, the horror of her 2022 accident and how she juggles familial and career ...